PVP Ventures acquires majority stake in 7Med India, Epitome Hospitals

PVP Ventures Limited announced on August 28, 2025, the acquisition of a majority stake in 7Med India Pvt. Ltd. and Epitome Group of Hospitals, a Delhi NCR-based healthcare enterprise specializing in nephrology, urology, and dialysis. This move marks a significant step in PVP's strategy to build a global healthcare services platform. The initial acquisition involves a 41.23% stake, with a clear path to majority shareholding within 12 months and a roadmap to increase ownership to 76% over time.

The transaction, comprising both primary and secondary stake purchases, amounts to an outlay of circa INR 127 crores for the majority shareholding. Subsequent investments will be contingent on achieving financial benchmarks. 7Med India operates 22 renal care centers and four super-specialty hospitals across six states, reporting an EBITDA of approximately INR 10 crore for the current financial year.

PVP Ventures intends to expand 7Med's network into multiple states and enhance healthcare infrastructure in tier 2 and tier 3 cities. This acquisition, as stated by Gaurav Davda, head of M&A and strategy at PVP Ventures Ltd., is a key part of creating a "powerful house of brands in healthcare services."